secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001562762-23-000174
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q1 revenue up 5.6% to $560M; adjusted EPS $4.82 (+0.6%)
--------------------------------------------------------------

- GAAP diluted EPS $3.58; adjusted diluted EPS $4.82, up 0.6% YoY.
- VITAS net patient revenue $310M (+3.8%), ADC 17,830 (+3.0%), but adjusted EBITDA margin fell 234 bps to 15.1% due to sequestration and hiring.
- Roto-Rooter revenue $250M (+7.9%), adjusted EBITDA $71.8M (+9.0%), margin 28.8% (+29 bps).
- Cash $58.1M, debt $21.3M; $405M undrawn revolver.
- Management will provide updated 2023 guidance in June 2023 earnings release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000156276223000174/0001562762-23-000174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000156276223000174/che-20230331x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-23-000174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer